NTHI - Neonc Technologies Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$16.00
DETAILS
HIGH:
$20.00
LOW:
$13.00
MEDIAN:
$15.00
CONSENSUS:
$16.00
UPSIDE:
363.77%
About Neonc Technologies Holdings, Inc. (https://www.neonctech.com)
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Thomas C. Chen | Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman | 1965 | $212,000 USD |
| Keithly A. Garnett | Chief Financial Officer | 1975 | $179,000 USD |
| Josh Neman-Ebrahim | Chief Clinical Officer | 1978 | $165,000 USD |
| Amir Farrokh Heshmatpour | President, Chief Executive Officer, Executive Chairman & Secretary | 1967 | – |
| David Choi | Chief Accounting Officer | – | – |